Keyoumars Soltani
Overview
Explore the profile of Keyoumars Soltani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boyle M, Ashi S, Puiu T, Reimer D, Sokumbi O, Soltani K, et al.
Am J Dermatopathol
. 2022 Feb;
44(5):360-367.
PMID: 35120032
Immune checkpoint inhibitors are increasingly being used in the treatment of various solid organ and hematologic malignancies. Dermatologic toxicities associated with programmed cell death protein-1 (PD-1) and programmed death ligand-1...
2.
Shah P, Qiang L, Yang S, Soltani K, He Y
Oncotarget
. 2017 Dec;
8(57):96522-96535.
PMID: 29228550
Nucleotide excision repair (NER) is the most versatile DNA repair pathway for removing DNA damage caused by UV radiation and many environmental carcinogens. NER is essential for suppressing tumorigenesis in...
3.
Qiang L, Sample A, Shea C, Soltani K, Macleod K, He Y
Autophagy
. 2017 Sep;
13(12):2086-2103.
PMID: 28933598
Macroautophagy (hereafter autophagy) is a cellular "self-eating" process that is implicated in many human cancers, where it can act to either promote or suppress tumorigenesis. However, the role of autophagy...
4.
Moioli E, Ligtenberg K, Kenkare S, Shea C, Soltani K
J Dermatol
. 2016 Apr;
43(10):1233-1234.
PMID: 27094584
No abstract available.
5.
Teng J, Cowen E, Wataya-Kaneda M, Gosnell E, Witman P, Hebert A, et al.
JAMA Dermatol
. 2014 Jul;
150(10):1095-101.
PMID: 25029267
Importance: The 2012 International Tuberous Sclerosis Complex Clinical Consensus Conference was convened to update the last consensus statement in 1998. Skin and dental lesions are common in tuberous sclerosis complex...
6.
Maitland M, Levine M, Lacouture M, Wroblewski K, Chung C, Gordon I, et al.
BMC Cancer
. 2014 Jan;
14:5.
PMID: 24386952
Background: Candidate predictive biomarkers for epidermal growth factor receptor inhibitors (EGFRi), skin rash and serum proteomic assays, require further qualification to improve EGFRi therapy in non-small cell lung cancer (NSCLC)....
7.
Bangash H, Patel S, Soltani K, Shea C, Sethi A
Int J Dermatol
. 2012 Nov;
51(12):1429-31.
PMID: 23171009
No abstract available.
8.
Zhang X, Hyjek E, Soltani K, Petronic-Rosic V, Shea C
Arch Pathol Lab Med
. 2012 Oct;
136(11):1402-7.
PMID: 23106586
Context: Pemphigus is a group of autoimmune vesiculobullous diseases characterized by immunoglobulin G (IgG) antibodies directed against desmosomal adhesion proteins, with IgG4 being the predominant subclass in active diseases. Direct...
9.
Kaminska E, Yu Z, Kress J, Petronic-Rosic V, Soltani K
Arch Dermatol
. 2012 Oct;
148(10):1199.
PMID: 23069962
No abstract available.
10.
Han W, Soltani K, Ming M, He Y
Cancer Prev Res (Phila)
. 2012 Aug;
5(9):1155-62.
PMID: 22846842
Skin cancer is the most common malignancy in organ transplant recipients, causing serious morbidity and mortality. Preventing and treating skin cancer in these individuals has been extraordinarily challenging. Following organ...